Skip to main content

Table 3 Mean (SD) of times and mean (95% CI) difference between times for all participants (n = 133)

From: Long-term effect of additional rehabilitation following botulinum toxin-A on upper limb activity in chronic stroke: the InTENSE randomised trial

Characteristic

Times

Difference between times

Month 0

Month 12

Month 12 minus Month 0

Upper limb activity n = 130 BBT (blocks/s)

0.03 (0.09)

0.04 (0.11)

0.01 (0.00 to 0.02)

Spasticity n = 45 Tardieu Scale (0–4)

2.0 (0.7)

1.5 (0.7)

-0.4 (-0.7 to -0.2)

Wrist extension ROM (deg)

37 (35)

27 (37)

-10 (-15 to -5)

Grip strength n = 130 MVC dynamometry (kg)

4.0 (5.1)

4.0 (4.9)

0.1 (-0.6 to 0.7)

Pain n = 132 10-cm VAS (0–10)

1.9 (2.6)

1.1 (2.0)

-0.8 (-1.2 to -0.3)

Burden of care CBS (0–16)

6.7 (3.9)

4.4 (3.9)

-2.3 (-3.1 to -1.4)

Quality of life, EQ-5D Overall health (0 to 100)

63 (21)

66 (23)

3 (-1 to 7)

  1. GAS Goal Attainment Scale, BBT Box and Block Test, ROM range of motion, MVC maximum voluntary contraction, VAS visual analogue scale, CBS Carer Burden Scale, EQ-5D EuroQual-5D